Inmune Bio Financial Overview
Inmune Bio's market cap is currently $50.25M. The company's EPS TTM is $-0.24; its P/E ratio is -0.86; Inmune Bio is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
